119 related articles for article (PubMed ID: 9339750)
1. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation.
Hempel L; Körholz D; Nussbaum P; Bönig H; Burdach S; Zintl F
Bone Marrow Transplant; 1997 Sep; 20(5):365-8. PubMed ID: 9339750
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
3. [Significance of interleukin 10 for acute graft versus host disease in children and adolescents after allogenic bone marrow transplantation].
Körholz D; Hempel L; Packeisen J; Kunst D; Zintl F; Burdach S
Klin Padiatr; 1996; 208(4):141-4. PubMed ID: 8926680
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
5. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
Remberger M; Ringden O; Markling L
Bone Marrow Transplant; 1995 Jan; 15(1):99-104. PubMed ID: 7742764
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Bonnotte B; Burdiles AM; Chehimi J; Carayol G; Pardoux C; Dietrich PY; Kubin M; Blay JY; Caignard A; Ibrahim A; Robinet E; Hayat M; Pico JL; Bourhis JH; Chouaib S
Eur Cytokine Netw; 1996 Sep; 7(3):389-94. PubMed ID: 8954182
[TBL] [Abstract][Full Text] [Related]
7. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation.
Weiss G; Schwaighofer H; Herold M; Nachbaur D; Wachter H; Niederwieser D; Werner ER
Transplantation; 1995 Dec; 60(11):1239-44. PubMed ID: 8525517
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.
Steffen M; Dürken M; Pichlmeier U; von dem Busche C; Stockschläder M; Krüger W; Budde-Steffen C; Zander A
Bone Marrow Transplant; 1996 Aug; 18(2):301-7. PubMed ID: 8864438
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
Nagler A; Bishara A; Brautbar C; Barak V
Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
[TBL] [Abstract][Full Text] [Related]
12. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
13. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
[TBL] [Abstract][Full Text] [Related]
14. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.
Schots R; Van Riet I; Othman TB; Trullemans F; De Waele M; Van Camp B; Kaufman L
Bone Marrow Transplant; 2002 Oct; 30(7):441-6. PubMed ID: 12368956
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
Yabe M; Yabe H; Hattori K; Shimizu T; Matsumoto M; Morimoto T; Yasuda Y; Inoue H; Kato S; Nishimura T
Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin 2 receptors in patients after bone marrow transplantation.
Siegert W; Josimovic-Alasevic O; Schwerdtfeger R; Baurmann H; Schmidt CA; Musch R; Schmid HJ; Hartmann R; Henze G; Huhn D
Bone Marrow Transplant; 1990 Aug; 6(2):97-101. PubMed ID: 2207458
[TBL] [Abstract][Full Text] [Related]
17. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
20. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
